All In Biotech

Drug Trial Radar · NCT01881763

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

Comparing Therapeutic Efficacy and Cognitive Side Effects of Electroconvulsive Therapy (ECT) Using Ketamine Versus Methohexital Anesthesia

Last checked: Nov 20, 2026Latest source record: Mar 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

31

Actual

Start

Jun 2010

Primary completion

Mar 2017

Study completion Jul 2017

Sponsor

Lead sponsor
Northwell HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Alliance for Research on Schizophrenia and Depression
First posted
Jun 20, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study aims to compare outcomes of Electroconvulsive Therapy (ECT) using ketamine versus methohexital anesthesia in depressed patients. The investigators hypothesize that patients who receive ketamine anesthesia during ECT will achieve remission status faster than those receiving methohexital anesthesia. Also, at the end of the ECT course subjects will display fewer cognitive side effects compared to those treated with methohexital anesthesia.

Conditions

  • Unipolar Depression
  • Bipolar Depression

Interventions

  • KetamineDrug

    Ketamine 1-2 mgr/ kg IV

  • MethohexitalDrug

    Methohexital 0.5-1mg/kg IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hamilton Rating Scale for Depression (HRSD) ImprovementTime frame: Days required to achieve remission (on average 3-4 weeks)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Zucker Hillside Hospital

    Glen Oaks, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.